Medication info
NP For 5/160 Milligrams

NP For 5/160 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Daehan New Pharm Co., Ltd.
Appearance
Dark yellow, rectangular film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201400703 · Approved 2014.02.17 · Insurance code 669905920

Summary

Main use
Treatment of essential hypertension not controlled with amlodipine or valsartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted before administering this medicine. However, if blood pressure is not adequately controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients undergoing dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years and older: Use caution when increasing the dose.
Child dose
Pediatric patients under 18 years of age: Administration of this medicine is not recommended because its safety and efficacy have not been established.

Ingredients

Manufacturer
Daehan New Pharm Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with amlodipine or valsartan monotherapy

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with amlodipine or valsartan alone. This drug helps achieve more effective lowering and control of blood pressure by using both medications together. This reduces the risk of cardiovascular complications due to hypertension and improves overall health status. In other words, it complements inadequate blood pressure control provided by monotherapy. Such treatment can help manage blood pressure tailored to the patient's condition. Therefore, this medication is used for effective blood pressure control in essential hypertension.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted before administering this medicine. However, if blood pressure is not adequately controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients undergoing dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years and older: Use caution when increasing the dose.

Child dose

Pediatric patients under 18 years of age: Administration of this medicine is not recommended because its safety and efficacy have not been established.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it must be stopped immediately upon confirmation of pregnancy. Patients allergic to any ingredients in this drug or similar medications, pregnant or nursing women, patients with severe kidney or liver disease, and patients with certain heart diseases should not take this medication. Patients with insufficient sodium or fluid may experience hypotension, so their condition must be closely monitored before starting the medication and during treatment, including careful observation of blood pressure and overall condition. Patients with high potassium levels or those taking medications that can raise potassium levels should have their potassium levels tested frequently, and caution is also needed for patients with poor kidney function. Patients who have undergone kidney transplantation or have a history of angioedema may experience side effects when taking this medication, so they need special attention. Patients with heart failure or after a myocardial infarction should carefully monitor kidney function and blood pressure changes while taking this medication, and patients with acute myocardial infarction should also be cautious with its use. This medication has blood pressure-lowering effects, and overdose may lead to dizziness, hypotension, and in severe cases, shock, so the prescribed dosage must be followed strictly. Dizziness or fatigue may occur during treatment, so caution is required when driving or operating machinery. When taking this medication with other blood pressure drugs, potassium supplements, diuretics, non-steroidal anti-inflammatory drugs (NSAIDs), etc., the risk of side effects may increase due to interactions, so consultation with a physician or pharmacist is recommended. Elderly patients may take a similar dose as adults, but caution is necessary based on their physical condition. This medication is not recommended for children under 18 years of age, as safety and efficacy have not been adequately established. If any abnormal symptoms or side effects occur during treatment, consult medical personnel immediately for appropriate measures.

Side effects

nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, orthostatic dizziness, sensory abnormality, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, thirst, rash, erythema, hyperhidrosis, rash, pruritus, joint swelling, low back pain, arthritis, muscle spasm, lethargy, polyuria, nocturia, erectile dysfunction, edema, periorbital edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, dysgeusia, peripheral neuropathy, muscular hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorders, nocturnal enuresis, gynecomastia, pain, fatigue, chest pain, weight loss, weight gain, elevated liver enzymes, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, neuroexcitability, sensory impairment, Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly closed container to prevent air or moisture from entering, and it is safe to store at room temperature between 1 degree and 30 degrees Celsius. Storing it this way preserves the medication's effectiveness and prevents degradation.

Appearance and packaging

Appearance

Dark yellow, rectangular film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.